PPLA is a New York–based pharmaceutical literature group that operates in the biopharma industry. Its filings show it has spent about $163,000 across six filings to lobby mainly on medical and disease research and issues affecting clinical labs. It retained the firm Richard J. Scholz, P.A. to represent its interests in these research and clinical lab matters.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
RICHARD SCHOLZ
The latest disclosures for this client.
RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)
4ARICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)
RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)
Q3RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)
Q3RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)
Q2RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)
Q1